Related Experiment Video
Updated: Jun 24, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Profiles of mortality among Chinese hypertensive patients in Hong Kong: a cohort study
J Y Jiang1, M C S Wong, X H Zhang
1Faculty of Medicine, School of Public Health and Department of Community and Family Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, Hong Kong, China.
Insights
This study found that major antihypertensive drug classes showed comparable risks for all-cause and cardiovascular mortality in Chinese patients. These real-world findings support current guidelines recommending various drug classes for initiating hypertension treatment.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension management involves selecting appropriate antihypertensive drug classes.
- Understanding the comparative mortality profiles of different antihypertensive agents is crucial for clinical decision-making.
- Existing guidelines suggest multiple drug classes are suitable for initiating hypertension pharmacotherapy.
Purpose of the Study:
- To investigate the association between different antihypertensive drug classes and all-cause and cardiovascular mortality.
- To compare the mortality profiles of alpha-blockers, thiazide diuretics, beta-blockers, calcium channel blockers (CCBs), and renin-angiotensin system (RAS) agents.
- To evaluate these associations in a large Chinese population within a real-world primary care setting.
Main Methods:
- A cohort study utilizing electronic patient records from Hong Kong's public primary care sector (January 2004-June 2007).
- Included 18,338 patients newly prescribed one of five major antihypertensive drug classes without drug switching or discontinuation.
- Cox proportional hazards regression analyses were used to evaluate odds ratios for all-cause and cardiovascular mortality.
Main Results:
- A total of 823 deaths (4.5%) occurred during the study period.
- Crude all-cause mortality was highest with alpha-blockers (6.2%) and CCBs (5.7%), and lowest with beta-blockers (2.8%).
- While thiazide diuretics showed statistically significantly lower all-cause and CVS mortality compared to CCBs, the 95% confidence intervals for mortality odds ratios overlapped across major drug classes, indicating comparable risks.
Conclusions:
- Antihypertensive drug classes were associated with statistically comparable odds of all-cause and cardiovascular mortality in this Chinese population.
- These real-life clinical practice findings support international guidelines recommending the suitability of major antihypertensive drug classes for initiating pharmacotherapy.
- The study reinforces the principle that various first-line antihypertensive agents can be effectively used for managing hypertension.
Abstract:
We studied the profiles of all-cause and cardiovascular (CVS) mortality among users of different antihypertensive classes in a Chinese population. From electronic patient records, a cohort study was conducted among 18,338 patients who ever newly prescribed an alpha-blocker, thiazide diuretic, beta-blocker, calcium channel blocker (CCB) or agents acting on the renin-angiotensin system (RAS) without drug discontinuation or switching in the public primary-care sector in a large Territory of Hong Kong during January 2004-June 2007. The odds ratios of mortality (all-cause and CVS) were evaluated according to the prescribed antihypertensive drug classes by Cox proportional hazards regression analyses. A total of 823 deaths (4.5%) were reported during the study period. The crude proportions of all-cause mortality were highest in alpha-blockers (6.2%) and CCB (5.7%), but lowest in beta-blockers (2.8%). Compared with CCB, patients on thiazide diuretics were shown to have statistically significantly lower all-cause (adjusted hazard ratios (aHRs) 0.75, 95% CI 0.60, 0.93, P=0.010) and CVS mortality (aHR 0.40, 95% CI 0.21, 0.78, P=0.007), but the 95% CI of the odds ratios of the major drug classes overlapped. When each drug class was used as a reference group, or when patients with only uncomplicated hypertension were included, their respective 95% CI similarly overlapped. Antihypertensive drug classes were associated with statistically comparable odds of all-cause and CVS mortality. This finding from real-life clinical practice further supports the position statements from international guidelines, which recommend that the major antihypertensive drug classes are suitable for initiating pharmacotherapy for the management of hypertension.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension II: Pathophysiology
Factors affecting Blood pressure
Physiological Factors:
Hypertension V: Nursing Management